BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30767072)

  • 1. Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations.
    Spudich JA
    Pflugers Arch; 2019 May; 471(5):701-717. PubMed ID: 30767072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state.
    Vander Roest AS; Liu C; Morck MM; Kooiker KB; Jung G; Song D; Dawood A; Jhingran A; Pardon G; Ranjbarvaziri S; Fajardo G; Zhao M; Campbell KS; Pruitt BL; Spudich JA; Ruppel KM; Bernstein D
    Proc Natl Acad Sci U S A; 2021 Jun; 118(24):. PubMed ID: 34117120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypertrophic cardiomyopathy mutations R403Q and R663H increase the number of myosin heads available to interact with actin.
    Sarkar SS; Trivedi DV; Morck MM; Adhikari AS; Pasha SN; Ruppel KM; Spudich JA
    Sci Adv; 2020 Apr; 6(14):eaax0069. PubMed ID: 32284968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-Onset Hypertrophic Cardiomyopathy Mutations Significantly Increase the Velocity, Force, and Actin-Activated ATPase Activity of Human β-Cardiac Myosin.
    Adhikari AS; Kooiker KB; Sarkar SS; Liu C; Bernstein D; Spudich JA; Ruppel KM
    Cell Rep; 2016 Dec; 17(11):2857-2864. PubMed ID: 27974200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity.
    Adhikari AS; Trivedi DV; Sarkar SS; Song D; Kooiker KB; Bernstein D; Spudich JA; Ruppel KM
    Nat Commun; 2019 Jun; 10(1):2685. PubMed ID: 31213605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of the N terminus of cardiac essential light chain promotes the super-relaxed state of myosin and counteracts hypercontractility in hypertrophic cardiomyopathy mutant mice.
    Sitbon YH; Kazmierczak K; Liang J; Yadav S; Veerasammy M; Kanashiro-Takeuchi RM; Szczesna-Cordary D
    FEBS J; 2020 Sep; 287(18):3989-4004. PubMed ID: 32034976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations.
    Nag S; Trivedi DV; Sarkar SS; Adhikari AS; Sunitha MS; Sutton S; Ruppel KM; Spudich JA
    Nat Struct Mol Biol; 2017 Jun; 24(6):525-533. PubMed ID: 28481356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered force generation and cell-to-cell contractile imbalance in hypertrophic cardiomyopathy.
    Kraft T; Montag J
    Pflugers Arch; 2019 May; 471(5):719-733. PubMed ID: 30740621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of myosin variants on interacting-heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes.
    Alamo L; Ware JS; Pinto A; Gillilan RE; Seidman JG; Seidman CE; Padrón R
    Elife; 2017 Jun; 6():. PubMed ID: 28606303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy.
    Toepfer CN; Garfinkel AC; Venturini G; Wakimoto H; Repetti G; Alamo L; Sharma A; Agarwal R; Ewoldt JK; Cloonan P; Letendre J; Lun M; Olivotto I; Colan S; Ashley E; Jacoby D; Michels M; Redwood CS; Watkins HC; Day SM; Staples JF; Padrón R; Chopra A; Ho CY; Chen CS; Pereira AC; Seidman JG; Seidman CE
    Circulation; 2020 Mar; 141(10):828-842. PubMed ID: 31983222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hypertrophic and dilated cardiomyopathy mutations on power output by human β-cardiac myosin.
    Spudich JA; Aksel T; Bartholomew SR; Nag S; Kawana M; Yu EC; Sarkar SS; Sung J; Sommese RF; Sutton S; Cho C; Adhikari AS; Taylor R; Liu C; Trivedi D; Ruppel KM
    J Exp Biol; 2016 Jan; 219(Pt 2):161-7. PubMed ID: 26792326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy mutations in the pliant and light chain-binding regions of the lever arm of human β-cardiac myosin have divergent effects on myosin function.
    Morck MM; Bhowmik D; Pathak D; Dawood A; Spudich J; Ruppel KM
    Elife; 2022 Jun; 11():. PubMed ID: 35767336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myosin motor domains carrying mutations implicated in early or late onset hypertrophic cardiomyopathy have similar properties.
    Vera CD; Johnson CA; Walklate J; Adhikari A; Svicevic M; Mijailovich SM; Combs AC; Langer SJ; Ruppel KM; Spudich JA; Geeves MA; Leinwand LA
    J Biol Chem; 2019 Nov; 294(46):17451-17462. PubMed ID: 31582565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical properties of human β-cardiac myosin with converter mutations that cause hypertrophic cardiomyopathy.
    Kawana M; Sarkar SS; Sutton S; Ruppel KM; Spudich JA
    Sci Adv; 2017 Feb; 3(2):e1601959. PubMed ID: 28246639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the super relaxed state of human β-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers.
    Anderson RL; Trivedi DV; Sarkar SS; Henze M; Ma W; Gong H; Rogers CS; Gorham JM; Wong FL; Morck MM; Seidman JG; Ruppel KM; Irving TC; Cooke R; Green EM; Spudich JA
    Proc Natl Acad Sci U S A; 2018 Aug; 115(35):E8143-E8152. PubMed ID: 30104387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic cardiomyopathy mutations in
    Toepfer CN; Wakimoto H; Garfinkel AC; McDonough B; Liao D; Jiang J; Tai AC; Gorham JM; Lunde IG; Lun M; Lynch TL; McNamara JW; Sadayappan S; Redwood CS; Watkins HC; Seidman JG; Seidman CE
    Sci Transl Med; 2019 Jan; 11(476):. PubMed ID: 30674652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of force-pCa relation in
    Yuan CC; Kazmierczak K; Liang J; Ma W; Irving TC; Szczesna-Cordary D
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35177471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tail length and E525K dilated cardiomyopathy mutant alter human β-cardiac myosin super-relaxed state.
    Duno-Miranda S; Nelson SR; Rasicci DV; Bodt SML; Cirilo JA; Vang D; Sivaramakrishnan S; Yengo CM; Warshaw DM
    J Gen Physiol; 2024 Jun; 156(6):. PubMed ID: 38709176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay.
    Debold EP; Schmitt JP; Patlak JB; Beck SE; Moore JR; Seidman JG; Seidman C; Warshaw DM
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H284-91. PubMed ID: 17351073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into human beta-cardiac myosin function from single molecule and single cell studies.
    Sivaramakrishnan S; Ashley E; Leinwand L; Spudich JA
    J Cardiovasc Transl Res; 2009 Dec; 2(4):426-40. PubMed ID: 20560001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.